HomeNASDAQ:GBT

NASDAQ:GBT

How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs

How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs

August 24, 2022

To Increase Its Presence in Rare Hematology, Pfizer Will Purchase Global Blood Therapeutics for $5.4 Billion.

To Increase Its Presence in Rare Hematology, Pfizer Will Purchase Global Blood Therapeutics for $5.4 Billion.

August 8, 2022